Early Phase 1 Migraine Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with migraines that meet specific international medical guidelines (called ICHD-3 criteria)
- After receiving a nerve block treatment, your headache pain dropped by at least 5 points on a pain scale, or your pain score afterwards was between 0 and 2 out of 10
- Your nerve block was performed using a specific numbing medication called bupivacaine 0.5%
Who may not be able to join:
- You have had a head injury or head trauma
- There is a suspicion that your headache may be caused by another condition, such as a stroke, a known brain tumor, or glaucoma
- Your headache is happening as part of a viral illness (such as the flu or a similar infection)
- You take steroid medications on a long-term, ongoing basis
- You have a known allergy to a medication called dexamethasone
- You cannot be contacted by phone or text message for follow-up after the trial
- You have gestational diabetes or any other type of diabetes that is not well controlled
- You have a condition or take medication that weakens your immune system
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Susan Watts, PhD., Texas Tech University Health Sciences Center, Department of Emergency Medicine
Phone: 915 215 4600
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Recurrence of headache
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.